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Abstract 
The plant Viburnum sambucinum has been known under the local name “Vót dạng cơm cháy” belongs to Viburnum 
genus, a member of the Caprifoliaceae family. Many plants of Viburnum genus are well known for their medicinal 
properties and are used in the folk medicine for the treatment of various diseases. A variety of structures have been 
reported from the plants of the genus, such as diterpenes, triterpenes, iridoids, sesquiterpenes, flavonoids, etc. In this 
study, we describe 3D cytotoxic and histone deacetylase (HDAC) inhibitory activities of two nordammarane 
triterpenoids hupehenol D (1) and 12β-hydoxy-3,15-dioxo-20,21,22-23,24,25,26,27-octanordammanrane (2) isolated 
from the leaves of Viburnum sambucinum. The result showed that (1) and (2) exhibited a strong activity against 3D 
models of LLC cell line with the IC50 value of 25.89 µM and 15.58 µM, respectively. Compound 1 weakly inhibited activity 
of enzyme HDAC with the IC50 of 20.78±2.86 M while compound 2 exhibited no effect on HDAC at 25 M. 
Keywords. Viburnum sambucinum, Caprifoliaceae, hupehenol D (1), 12β-hydoxy-3,15-dioxo-20,21,22-
23,24,25,26,27-octanordammanrane (2), 3D cytotoxic, HDAC inhibitory activity. 
 
1. INTRODUCTION 
 
Cancer is one of the leading cause of death and 
globally the numbers of new cases of cancer are 
increasing gradually [1]. Current estimates from the 
American Cancer Society indicate that 7 million 
deaths worldwide, these numbers are expected to 
double by 2030 [2]. Thus, there is an increasing need 
for new and effective drugs for the disease treatment. 
Plants have a long history of use in the treatment 
of cancer and it is significant that over 60 % of 
currently used anticancer agents are either natural 
products or directly derived therefrom [3]. 
The genus Viburnum (Caprifoliaceae) comprises 
about 200 species of shrubs and trees, which are 
widely distributed in the temperate or subtropical 
zones, from Southern America to Asia [4]. Many 
species of the genus Viburnum are employed as folk 
medicine to treat different diseases, such as cough, 
diarrhea, rheumatoid arthritis, and tumefaction. 
Recently, much attention has been paid to Viburnum 
genus and their chemical constituents because of 
their multifaceted activities. Extensive studies of 
Viburnum genus have led to the identification of 
many compounds, such as diterpenes, triterpenes, 
iridoids, monoterpenes, sesquiterpenes flavonoids, 
lignans, etc. Especially, vibsan diterpenoids and 
triterpenoids are dominant and interesting 
bioactivities compounds [5-7]. In a previous study, 
we described chemical structure and 2D cytotoxic 
activity of 10 compounds isolated from the leaves of 
Viburnum sambucinum, among them, two 
nordammarane triterpenoids hupehenol D (1) and 
12β-hydoxy-3,15-dioxo-20,21,22-23,24,25,26,27-   
 
 
Figure 1: Chemical structure of hupehenol D (1) and 
12β-hydoxy-3,15-dioxo-20,21,22-23,24,25,26,27-
octanordammanrane (2) 
 
octanordammanran (2) exposed potential cytotoxic 
activity on several human cancer cell lines with 
IC50 value of 4.71±0.03-5.35±0.04 μM, respectively 
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[8]. Therefore, in this present study, these compounds 
were used to investigate the 3D cytotoxicity and 
histone deacetylase (HDAC) inhibitory activity on 
cancer cells. 
 
2. MATERIALS AND METHODS 
 
2.1. Cancer cell lines 
 
MCF-7 (HTB - 22
TM
): Human breast carcinoma was 
purchased from American Type Culture Collection 
(ATCC); LLC (Murine Lewis lung carcinoma) was 
kindly provided by Prof. Jeanette Maier, Milan 
University, Italia. Those cancer cells were 
continuously cultured in Department of Applied 
Biochemistry, Institute of Chemistry, Vietnam 
Academy Science and Technology.  
 
2.2. Histon deacetylases (HDAC) activity 
colorimetric kit 
 
Histone deacetylases enzyme (HDAC) inhibit 
activity was determined by HDAC Activity 
Colorimetric assay Kit (BioVision-US) on MCF7 
cancer cell lines. Kit components: HDAC substrate 
(Boc-Lys(Ac)-pNA, 10 mM), 10x HDAC Assay 
buffer, Lysine Developer, HDAC inhibitor 
(Trichostatin A, 1mM), Hela nuclear extract (5 
mg/ml), Deacetylated Standard (Boc-Lys-pNA, 10 
mM). 
 
2.3. 3D cytotoxic activity assay 
 
3D LLC cell line culture method:  
LLC cancer cells was monolayer maintained in 
medium DMEM supplemented 2 mM L-glutamine, 
10 mM HEPES, 1.0 mM sodium pyruvate, 10 % 
fetal bovine serum-FBS (GIBCO).  Cells were 
transfered with ratio 1:3 every 3-5 days and 
incubated in a humidified atmosphere of 5 % CO2 at 
37 
o
C. Using trypsin-EDTA to detach cells and then 
resuspended in culture medium. Using Fisher 
scientific hemacytometer cat 0267110 (Hauser, 
USA) to calculated cells. Then, multicellular tumor-
spheroids (MCTSs) were cultured on plate with agar 
medium. 190 µl cell solution (5000 cells/well) were 
plated in DMEM medium with 10 % FBS. After 3-4 
days’ culture at 37 oC in an atmosphere containing 5 
% CO2, the spheroids were formed and ready to used 
[9]. 
 
Invitro 3D cytotoxic activity assay 
The 3D cytotoxicity of samples on LLC cell lines 
were dertermined by the MTT assay [10]. After 72 
hours incubation, the cell reaches the confluence. 
Then, cells were incubated in the presence of 
various concentrations of the samples in 0.1 % 
DMSO for 48 h at 37 °C/5 % CO2. Ellipticine was 
used as reference. 20 µl/well of 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-tetrazolium bromide (MTT) 
were added. After 4 h incubation, removed medium, 
100 µl DMSO were added/well and shake 5-10 
minutes. Viable cells were determined by microplate 
spectrophotometer at 490 nm.  
 
Statistical analysis  
A percent inhibition was calculated using the 
following formula:  
 
All the experimental results were as mean ± 
standard deviation (SD) of three parallel 
measurements. The data was entered into Microsoft 
Excel
©
 database and analyzed using Table Curve 
giving IC50.  
 
2.4. HDAC inhibitory activity assay 
 
Principle of assay 
Inhibition of histone deacetylases (HDACs) has 
been implicated only two simple steps. HDAC 
catalyze the removal of -acetylated lysine group of 
substrate Boc-Lys(Ac)-pNA (step 1). So that, the 
second step, substrate Boc-Lys(Ac)-pNA was 
continuously removed by Lysine Developer to 
release yellow pNA (p-nitroaniline) can be easily 
analyzed using ELISA plate reader at 400-405 nm. 
Procedure 
HDAC inhibitory activity of samples was 
measured with HDAC Colorimetric Assay Kit 
(BioVision- US).  
MCF7 cell line was grown in medium DMEM 
supplemented 2 mM L-glutamine, 10 mM HEPES 
and 1.0 mM sodium pyruvate, 10 % FBS (GIBCO) 
and incubated in a humidified atmosphere of 5 % 
CO2 at 37 
o
C. Cells were havested into plate and 
incubated overnight. After removal of  medium and 
washing with phosphate-buffered saline (pH 7.4), 
cells were harvested and using Nuclear/Cytosol 
Fractionnation KIT (Biovision) to obtain nuclear 
extract. Samples were mixed with Hela nuclear 
extract that contains a variety of HADC enzymes 
and has HDAC activity. Then, cells were incubated 
for 24-48 h at 37 °C. HDAC colorimetric substrate 
was added to inhibitor and Hela nuclear extract 
mixture. Incubated in 37 
o
C for 1h. 10 l Lysine 
Developer was added to stop the reaction and 
incubate for 30 minutes in 37 
o
C. A color is 
developed after 1hour treatment with the lysine 
developer. Absorbance at 400-405 nm was measured 
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by microplate reader equipment. Trichostatin A was 
used as a reference. 
 
Statistical analysis 
A percent HDAC inhibition  was calculated using 
the following formula: 
 
The data was expressed as mean±SD from three 
independent experiments. The data was entered 
into Microsoft Excel
©
 database and analyzed using 
Table Curve 2Dv4 giving IC50.  
 
3. RESULTS AND DISCUSSION 
 
3.1. 3D cell culture cytotoxic activity 
 
Cell-based assays are the key tool used to assess the 
potential efficacy of a new compound in drug 
discovery. Most of the commonly used cytotoxic 
anticancer drugs were discovered through random 
high-throughput screening in cell-based cytotoxicity 
assays [11]. In general, cell culture modes include 
monolayer cells on a two-dimensional (2D) surface 
and multilayer cells or aggregate clusters in a three-
dimensional (3D) scaffold [12]. To date, 2D cell-
based assays in multiwell  plates are widely used in 
drug screening because of their low costs and easy 
operation. However, 2D cell cultures can result in 
errors in predicting tissue-specific responses due to 
the loss of native morphology and limited cell-cell 
and cell-extracellular matrix interactions [13]. 
Recently, research has found that 3D cell cultures 
provide a more physiologically relevant environment 
for cells and allow the study of cellular responses to 
drug treatment more closely to what occurs in vivo 
than 2D model [14-16].  
In our previous report, two nordammarane 
triterpenoids hupehenol D (1) and 12β-hydoxy-3,15-
dioxo-20,21,22-23,24,25,26,27  
octanordammanrane (2) isolated from leaves of 
Viburnum sambucinum exposed strong cytotoxic 
activity on 4 cancer cell lines: KB, HepG2, Lu1 
and MCF7 with IC50 values in range of 4.71±0.03-
5.35±0.04 µM. In this study, two of these 
compounds were evaluated cytotoxicity  on 3D 
spheroid model. The results are shown in figure 2 
and table 1. 
 
Figure 2: Images of LLC 3D spheroids  after 3 days treating by 1 and 2 3D spheroids treating by compound 
1 at 100 µg/ml (A), 20 µg/ml (B), 4 µg/ml (C) 3D spheroids treating by compound 2 at 100 µg/ml (D), 4 
µg/ml (E) 3D spheroids without compounds (F) 
 
Table 1: Cytotoxic activity of compounds (1) and (2) on 3D LLC cell culture 
Test concentration 
(µg/ml) 
% inhibit Test concentration 
(µg/ml) 
% inhibit 
Compound (1) Compound (2) Ellipticine 
100 94.11 95.88 10  64.36 
20 92.05 83.80 2  24.01 
4 19.00 57.58 0.4   7.51 
0.8 -3.09 2.36 0.08  -4.57 
IC50 
8.96±2.95 µg/ml 5.36±1.53 µg/ml 
IC50 
6.30±0.22 µg/ml 
25.89±8.52 µM 15.58±4.44 µM 25.61±0.89 µM 
 
From figure 2, we can obviously observe the 
mophological parameters of 3D spheroid after being 
treated with compounds 1 and 2. At 20 µg/ml and 
100 µg/ml concentration of compounds 1 and 2, 
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external proliferating layers of spheroids were 
gradually darkened, unstable, indistinguishable to 
necrotic core and the structure of spheroids were 
deformed. Volume of spheroid also were decreased 
compare to control. Especially, tumor spheroid 
treated by compound 2 at 100 µg/ml were 
disintegrated, highly variability to control. 
3D spheroid cytotoxic ability of agents were also 
reflected by the IC50 value. The results shown in 
Table 1 indicated that two compounds 1 and 2 again 
exhibited a strong activity against LLC with the IC50 
value of 25.89 µM and 15.58 µM, respectively. 
Ellipticine showed the IC50 value of 25.61 µM. 
Compare IC50 between 2D and 3D cell models, the 
IC50 value of compounds 2 and 1 gained from the 3D 
culture model is 3-5 fold higher than those from the 
2D model, respectively. This finding is in 
concordance with several studies showing that 
cultured cells on 3D are more resistant to drug than 
on 2D models.  A number of studies have found that 
cells cultured in 3D models are more resistant to 
anticancer drugs than 2D cultures. For example, 
ovarian cancer cell survival and proliferation in 3D 
cultures after paclitaxel treatment was reduced by 40 
% or 60 % in 3D cell spheroids, while the same 
treatment led to 80 % reduced cell viability in the 
2D cell monolayer [17]. Karlsson et al. studied the 
drug sensitivity of colon cancer HCT-116 cells in a 
3D spheroid and 2D monolayer model in response to 
four standard anticancer drugs (melphalan, 5-FU, 
oxaliplatin, and irinotecan) and two promising 
investigational cancer drugs (acriflavine and 
VLX50. The results indicated that all drugs were 
highly active in 2D monolayer culture but generally 
less active and gradually lost their activity in 3D 
spheroids [18]. The stronger drug resistance in 3D 
culture results primarily from signals from dynamic 
cellular interactions between neighboring cells and 
extra cellular matrix input into the cellular decision-
making process. The increased drug resistance in 3D 
culture can also be attributed to limited diffusion 
through the spheroid and to hypoxia, cause by 
multilayer cells spheroid form [14, 18]. 
Recently, a growing body of evidence has shown 
that 3D cell cultures provide a more physiologically 
relevant environment for cells and allow the study of 
cellular responses in a setting that more closely 
resembles in vivo environments. A number of 
studies have demonstrated that cellular behavior in 
3D cultures rather than 2D culture occur more 
similarly to those in vivo. Therefore, there is a great 
need for in vitro 3D cell culture assays, which would 
bridge the 2D monolayer cell culture systems and 
the animal models [12,19].  
 
3.2. HDAC ihibitory activity results 
 
Histone dacetylases (HDACs) are a group of 
enzymes that remove acetyl groups from histones 
which are the primary protein components of 
chromatin. HDACs play a major role in the 
epigenetic regulation of gene expression through 
their effects on the compact chromatin structure. In 
recent years, alterations in acetylate levels and over 
expression of various HDACs in many cancer cell 
lines and tumor tissues have been reported. 
Therefore, HDACs have become promising 
therapeutic target for cancer treatment [20]. 
In the next experiment, compounds 1 and 2 
continuously were evaluated HDAC inhibit activity 
on MCF7 to initially explore mechanism of 
cytotoxicity of them. MCF7 cell line was treated 
with different concentration of compounds. 
Negative control contain cells only, no reagents. The 
results were displayed in table 2. 
 
Table 2: HDAC inhibitory activity of the compounds 1 and 2 in MCF7 cells 
Test concentration 
 (µM) 
% inhibit Test concentration 
(µM) 
% inhibit 
Compound (1) Compound (2) Trichostatin A 
21 51.12 35.32 1 82.0 
14 40.02 37.14 0.1 74.23 
7 35.74 28.91 0.01 56.89 
3.5 14.83 2.45 0.001 42.19 
IC50 20.78±2.86 µM > 21 µM IC50 3.1±0.5 nM 
 
Histone deacetylases enzyme (HDAC) inhibitory 
activity of compounds 1 and 2 was determined by 
HDAC Activity Colorimetric assay kit (BioVision- 
US) on MCF7 cancer cell lines. As shown in table 2, 
compound 1 weakly inhibited activity of enzyme 
HDAC with the IC50 of 20.78±2.86 M while the 
reference Trichostatin A possessed the IC50 of 3.1±0.5 
nM. Compound 2 exhibited no inhibition activity of 
enzyme HDAC at the highest testing concentration 
which was 25 M. This finding suggests that 
anticancer mechanism of 1 and 2 do not act over the 
inhibition of HDAC enzymes and should be explored 
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in further studies.  
 
4. CONCLUSION 
 
Two triterpenoid  hupehenol D (1) and 12β-hydoxy-
3,15-dioxo-20,21,22-23,24,25,26,27-
octanordammanrane (2) derived from leaves of 
Viburnum sambucinum were evaluated 3D cytotoxic 
and HDAC inhibitory activities for the first time. 
They displayed strong 3D cytotoxic activity on LLC 
spheroids with IC50 value of 3D cell is higher 3-5 
fold than 2D cells. However, both compounds 
showed insignificant HDAC inhibitory activity.  
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